Product Description
Product Name: Ledipasvir 90 mg + Sofosbuvir 400 mg Tablets
Form: Oral Tablet
Category: Direct-Acting Antiviral (DAA) Combination Therapy
Indication: Chronic Hepatitis C Virus (HCV) Infection – Genotypes 1, 4, 5, and 6
Ledipasvir (90 mg) + Sofosbuvir (400 mg) is a fixed-dose combination antiviral medication used in the treatment of chronic Hepatitis C virus (HCV) infection. It is primarily indicated for genotypes 1, 4, 5, and 6, and offers a convenient, interferon-free oral therapy with high cure rates across diverse patient populations.
